NCT05546879
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05546879
Title Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable Hepatocellular Carcinoma (Liver-NET1)
Acronym Liver-NET1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Hospital, Grenoble
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
CHU de GRENOBLE ALPES Grenoble Alpes 38043 France Details
CHU Angers Angers France Details
Hôpital Haut Lêveque Bordeaux France Details
12 Hôpital St Joseph Marseille France Details
CHU Nantes Nantes France Details
AP-HP Beaujon Paris France Details
AP-HP St Antoine Paris France Details
CHU Reims Reims France Details
CHU Toulouse Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field